An expert panel evaluated 23 separate statements related to the etiology, diagnosis, and treatment of gout.
Patients with gout who did not reach a serum uric acid level below 6 mg/dL had a 2.4-fold increased risk for death.
In a British study, nurse-led care emphasizing patient education and engagement significantly improved the proportion of gout sufferers who achieved target serum urate levels.
Linked to small increase in mortality; at 2 years, 31% of dose escalators achieved serum urate goal.
Ethnicity and hypertension have an association with incident gout that is not fully explained by differences in serum urate.
Preliminary clinical trial results show more heart-related deaths occur in patients taking febuxostat compared to allopurinol.
The DASH diet could offer a dietary strategy that may help prevent gout and its comorbidities in high-risk patients with hyperuricemia.
Ample opportunities exist to increase clinician's knowledge of gout identification and management.